Clinical Trials Directory

Trials / Completed

CompletedNCT01202552

Two-site Intradermal Influenza Vaccination in Elderly

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Queen Saovabha Memorial Institute · Academic / Other
Sex
All
Age
60 Years – 100 Years
Healthy volunteers
Accepted

Summary

One-site dose sparing intradermal influenza vaccination in elderly had been studied but resulted in unsatisfactory outcomes. The investigators evaluate the safety and immunogenicity of the two-site intradermal injection of influenza vaccine containing all 6 and 12 micrograms of hemagglutinin antigen per strain (with 4/10th and 8/10th of a regular 15 microgram HA/strain intramuscular vaccine respectively) in elderly over 60 years of age. An influenza vaccine administered intramuscularly at the standard dose is used as the reference vaccine.

Detailed description

The subjects would be randomly divided into three groups of 60 subjects each. Group1 receives a single intramuscular dose of 0.5 ml of trivalent influenza vaccine, containing at least 15 microgram of hemagglutinin antigen per strain, Group II receives two-site intradermal dose of 0.1 ml each, containing at least 3 microgram of hemagglutinin antigen per strain per site and group III receives two-site intradermal dose of 0.2 ml each, containing at least 6 microgram of hemagglutinin antigen per strain per site. Check for HA Antibody

Conditions

Interventions

TypeNameDescription
BIOLOGICALseasonal influenza vaccinereceives a single intramuscular dose of 0.5 ml of trivalent influenza vaccine, containing at least 15 microgram of hemagglutinin antigen per strain
BIOLOGICALseasonal influenza vaccinereceives two-site intradermal dose of 0.1 ml each, containing at least 3 microgram of hemagglutinin antigen per strain per site and group
BIOLOGICALseasonal influenza vaccinereceives two-site intradermal dose of 0.2 ml each, containing at least 6 microgram of hemagglutinin antigen per strain per site

Timeline

Start date
2010-10-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2010-09-16
Last updated
2018-04-06

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01202552. Inclusion in this directory is not an endorsement.

Two-site Intradermal Influenza Vaccination in Elderly (NCT01202552) · Clinical Trials Directory